{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/recent","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-07T01:52:08.863Z"},"count":4,"filters":{"office":"The Office of Prescription Drug Promotion (OPDP)"},"items":[{"id":"362882de23e0f7ba","posted_date":"2026-03-24","letter_issue_date":"2026-03-13","company_name":"ImmunityBio, Inc.","issuing_office":"The Office of Prescription Drug Promotion (OPDP)","subject":"False & Misleading Claims/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/362882de23e0f7ba"},{"id":"0201bf9e10f8a1b5","posted_date":"2025-05-20","letter_issue_date":"2025-04-25","company_name":"Sarfez Pharmaceuticals, Inc.","issuing_office":"The Office of Prescription Drug Promotion (OPDP)","subject":"False & Misleading Claims/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/0201bf9e10f8a1b5"},{"id":"730e5c406ade6e11","posted_date":"2023-08-15","letter_issue_date":"2023-08-04","company_name":"AstraZeneca Pharmaceuticals LP","issuing_office":"The Office of Prescription Drug Promotion (OPDP)","subject":"False & Misleading Claims/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/730e5c406ade6e11"},{"id":"e5365a221ae238cd","posted_date":"2021-02-16","letter_issue_date":"2021-02-11","company_name":"AcelRx Pharmaceuticals, Inc.","issuing_office":"The Office of Prescription Drug Promotion (OPDP)","subject":"False & Misleading Claims/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/e5365a221ae238cd"}]}